Navigation Links
Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented
Date:4/27/2010

The American Gastroenterological Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) announced this year's recipient of the Bernard Lee Schwartz Foundation Research Scholar Award Kenneth P. Olive, PhD. The $225,000 gift from the Bernard Lee Schwartz Foundation will provide Dr. Olive with funding and protected time for three years to focus on basic science related to pancreatic cancer. Mr. Schwartz, a businessman and photographer, suffered from the disease and died in 1978 at the age of 64. His family has honored his memory by establishing this new three-year Research Scholar Award for pancreatic cancer research.

Dr. Olive has focused his research on digestive diseases, specifically towards identifying better treatment modalities for pancreatic cancer. He has already made several important research contributions, including first-authoring papers in Cell, Science, Cancer Research and Clinical Cancer Research. His research efforts have also been recognized by the American Association for Cancer Research and the National Institutes of Health.

Described by colleagues as an innovative investigator and an emerging star in the field of pancreatic cancer work, Dr. Olive will focus his research on the influence of hedgehog pathway inhibition on pancreatic cancer metastasis.

"The research support provided by the Bernard Lee Schwartz Foundation is helping to answer important questions in the study of pancreatic cancer," said Sidney Cohen, MD, AGAF, chair of the AGA foundation. "The research funded by the Bernard L. Schwartz Research Scholar Award in Pancreatic Cancer will continue to contribute to the advancement of our knowledge of the early detection and treatment of this devastating disease. We are most grateful for the Schwartz family's continued confidence in the research scholars of the AGA foundation."

This is the second Research Scholar Award in Pancreatic Cancer funded by the Bernard Lee Schwartz Foundation. The first recipient, Kenneth H. Yu, MD, of the University of Pennsylvania, has focused his research on identifying screening protein markers associated with pancreatic tumors, which will yield a test to detect the disease at an early stage.

"We think that bringing young, capable and innovative investigators to work on finding a cure for pancreatic cancer is a worthy endeavor and one which will yield results," said the Schwartz family. "AGA recognizes the critical need for new research talent, which is focused on this area, and we are delighted to be their partner in creating this research award. We believe that progress toward a cure for pancreatic cancer will come from the concentrated efforts of smart investigators who have the resources they need and enough dedicated time to do their work."

Pancreatic cancer is the fourth leading cause of cancer deaths; more than 35,000 estimated deaths were expected to occur in 2009. More than 42,000 cases of pancreatic cancer were expected to be diagnosed in 2009. Currently, there are no methods for the early detection of pancreatic cancer; only 7 percent of cases are diagnosed in the early stages. The one-year survival rate for pancreatic cancer is 24 percent and the five year survival rate is 5 percent; when the disease is identified in the early states, the five-year survival is only 20 percent.


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES
2. Smokers Own Secondhand Smoke Adds to Health Risks
3. New model of skin cancer provides insights on second-most common type of cancer
4. As Kids Age, Secondary Schools Offer Less Support
5. Smokers at risk from their own second-hand smoke
6. Mental illnesses are second leading cause of time off work in Spain
7. Saint Thomas Hospital Ranked Top Five Percent in Nation for the Second Consecutive Year According to Quality Study
8. You Never Get a Second Chance to Make a First Impression: High-Definition for the Web
9. SOKO Fitness Reports Second Quarter Fiscal 2010 Results
10. Northern California Cancer Centers Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research
11. Allscripts to Announce Second Quarter Fiscal 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
Breaking Medicine Technology: